Literature DB >> 12430848

Bone marrow transplantation for non-malignant disease.

Keith M Sullivan1.   

Abstract

Mesh:

Year:  2002        PMID: 12430848     DOI: 10.1007/bf03165239

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

1.  High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

Authors:  Peter A McSweeney; Richard A Nash; Keith M Sullivan; Jan Storek; Leslie J Crofford; Roger Dansey; Maureen D Mayes; Kevin T McDonagh; J Lee Nelson; Theodore A Gooley; Leona A Holmberg; C S Chen; Mark H Wener; Katherine Ryan; Julie Sunderhaus; Ken Russell; John Rambharose; Rainer Storb; Daniel E Furst
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

2.  Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease.

Authors:  M C Walters; R Storb; M Patience; W Leisenring; T Taylor; J E Sanders; G E Buchanan; Z R Rogers; P Dinndorf; S C Davies; I A Roberts; R Dickerhoff; A M Yeager; L Hsu; J Kurtzberg; K Ohene-Frempong; N Bunin; F Bernaudin; W Y Wong; J P Scott; D Margolis; E Vichinsky; D A Wall; A S Wayne; C Pegelow; R Redding-Lallinger; J Wiley; M Klemperer; W C Mentzer; F O Smith; K M Sullivan
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

Review 3.  High-dose cyclophosphamide for aplastic anemia and autoimmunity.

Authors:  Robert A Brodsky
Journal:  Curr Opin Oncol       Date:  2002-03       Impact factor: 3.645

4.  Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.

Authors:  M C Walters; M Patience; W Leisenring; Z R Rogers; V M Aquino; G R Buchanan; I A Roberts; A M Yeager; L Hsu; T Adamkiewicz; J Kurtzberg; E Vichinsky; B Storer; R Storb; K M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

Review 5.  The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases.

Authors:  K M Sullivan; D E Furst
Journal:  J Rheumatol Suppl       Date:  1997-05

Review 6.  Stem cell transplantation for aplastic anemia.

Authors:  George E Georges; Rainer Storb
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

7.  Bone Marrow Transplantation for Non-Malignant Disease.

Authors:  Keith M. Sullivan; Robertson Parkman; Mark C. Walters
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2000

8.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Authors:  Edwin M Horwitz; Patricia L Gordon; Winston K K Koo; Jeffrey C Marx; Michael D Neel; Rene Y McNall; Linda Muul; Ted Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

9.  Bone marrow transplantation in thalassemia. The experience of Pesaro.

Authors:  G Lucarelli; M Galimberti; C Giardini; P Polchi; E Angelucci; D Baronciani; B Erer; D Gaziev
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

10.  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Authors:  Alessandro Aiuti; Shimon Slavin; Memet Aker; Francesca Ficara; Sara Deola; Alessandra Mortellaro; Shoshana Morecki; Grazia Andolfi; Antonella Tabucchi; Filippo Carlucci; Enrico Marinello; Federica Cattaneo; Sergio Vai; Paolo Servida; Roberto Miniero; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  1 in total

1.  Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report.

Authors:  Wencui Chen; Guisheng Ren; Ke Zuo; Xianghua Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.